Here are five observations:
1. Vantage mHealthcare does not want its name to be confused with other businesses bearing the “Vantage” name.
2. The company has been developing a screening device that will detect human breath components to catch chronic diseases likes heart failure and cancer earlier.
3. The sensor connects via Bluetooth to smart devices running an iOS or Android system.
4. The current Breathalyzer is composed of the breath capture device, sensor module and software for smart devices.
5. This device is collecting sample data from test patients for key biomarkers in a clinical setting.
“The sensor and related devices will ultimately be used to demonstrate an integrated approach that can be used to collect data from human breath and evaluate if for early disease screening purposes…,” said Joseph C. Peters, president of Vantage mHealthcare.
Recent articles:
Health Net Federal awarded full URAC HIPAA Privacy reaccreditation: 5 notes
72-hour stays could still come to Florida: 3 things to know
7 things for ASC leaders to know for Thursday — August 13, 2015
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
